Marsha Fanucci

Insider Reports History

Entity
Individual
Location
Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, MA
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marsha Fanucci:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syros Pharmaceuticals, Inc. Director Common Stock 16K $79.2K $4.95 Jun 5, 2024 Direct
Cyclerion Therapeutics, Inc. Director Stock Option (Right to Buy) 20K Jun 14, 2022 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6K Jun 5, 2024 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 3.45K May 18, 2023 Direct
Forma Therapeutics Holdings, Inc. Director Common Stock 0 $5.05 Oct 14, 2022 Direct
Forma Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 Oct 14, 2022 Direct

Insider Reports Filed by Marsha Fanucci

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRS Syros Pharmaceuticals, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 18, 2023 1 $0 4 May 19, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director
FMTX Forma Therapeutics Holdings, Inc. Oct 14, 2022 7 $0 4 Oct 14, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2022 2 $0 4 Sep 19, 2022 Director
CYCN Cyclerion Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
FMTX Forma Therapeutics Holdings, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 18, 2022 1 $0 4 May 20, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 23, 2022 1 $0 4 Feb 25, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Jul 15, 2021 1 $0 4 Jul 19, 2021 Director
CYCN Cyclerion Therapeutics, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
FMTX Forma Therapeutics Holdings, Inc. Jun 17, 2021 2 $0 4 Jun 21, 2021 Director
SYRS Syros Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director